Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation Of Receipt Of Request For Reclassification From ''''Promoter Group'''' Category To ''''Public'''' Category.

 This is to inform that the Company is in receipt of letter dated 12th May, 2022 from the Promoter requesting it''s reclassification from ''''Promoter'''' category to ''''Public'''' category shareholders of the Company in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
12-05-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayAspira Pathlab & Diagnostics Ltd 2CINL85100MH1973PLC289209 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Priya Pandey Designation: Company Secretary and Compliance Officer EmailId: priya.pandey@aspiradiagnostics.com Name of the Chief Financial Officer: Balkrishna Talawadekar Designation: Chief Financial Officer EmailId: balkrishna.talawadekar@aspiradiagnostics.com Date: 23/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
23-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indian Co-operative Credit Society Ltd
22-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clean EV Technologies Pvt Ltd
22-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Smartech Innovations Pvt Ltd
22-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year March 31, 2022

 Pursuant to Regulation 40(9) of the SEBI (LODR) Regulations, 2015, please find enclosed herewith the Certificate for the year ended March 31, 2022. Kindly take the same on your record.
21-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 This is to inform you that, Yashraj Biotechnology Limited belongs to Promoter and Promoter Group has sold 5500000, 9% Non-Convertible Non-Cumulative Non-Participating Redeemable Preference Shares at Rs. 10/- each to Smartech Innovations Private Limited, Clean EV Technologies Private Limited, Indian Co-operative Credit Society Limited. Kindly take the same on your record.
20-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliance Certificate Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2022

 Dear Sir/Madam, Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Compliance Certificate for the year ended March 31, 2022 duly signed by the Compliance Officer of the Company and the authorized representative of the Share Transfer Agent viz. M/s. Link Intime India Private Limited, certifying compliance with the requirements of Regulation 7(2) of the said Regulations. Kindly take the same on your record.
18-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Appointment of Company Secretary and Compliance Officer

 Appointed Ms. Priya Pandey, Associate Member of the Institute of Company Secretaries of India, as the Company Secretary and Compliance Officer and designated as a Key Managerial Personnel of the Company w.e.f. 16th April, 2022.
16-04-2022
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, for the quarter ended 31st March, 2022.
08-04-2022
Next Page
Close

Let's Open Free Demat Account